Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemiaBritish Journal of Haematology.  185:169-174. 2019
2019 Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemiaOncogene.  38:2241-2262. 2019
2019 Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRALeukemia.  33:771-775. 2019
2019 Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinicallyLeukemia2019
2019 Hematopoietic stem-cell transplantation does not improve the poor outcome of children with hypodiploid acute lymphoblastic leukemia: A report from children's oncology groupJournal of Clinical Oncology.  37:780-789. 2019
2018 NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcomeLeukemia.  32:2536-2545. 2018
2018 Improved survival for children and young adults with t-lineage acute lymphoblastic leukemia: Results from the children's oncology Group AALL0434 methotrexate randomizationJournal of Clinical Oncology.  36:2926-2934. 2018
2018 Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the children’s oncology groupBlood.  132:815-824. 2018
2018 Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome–positive acute lymphoblastic leukemia: Results of children’s oncology group trial AALL0622Journal of Clinical Oncology.  36:2306-2313. 2018
2018 Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission.Blood Adv.  2:1645-1650. 2018
2018 Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG)Leukemia.  32:1370-1379. 2018
2018 Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: An analysis of Alliance studiesLeukemia.  32:1338-1348. 2018
2018 Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131Cancer.  124:1150-1159. 2018
2018 TP53 germline variations influence the predisposition and prognosis of b-cell acute lymphoblastic leukemia in childrenJournal of Clinical Oncology.  36:591-599. 2018
2017 Flow cytometric vs morphologic assessment of remission in childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG).Leukemia2017
2017 Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemiaBritish Journal of Haematology.  179:843-846. 2017
2017 Impact of initial CSF findings on outcome among patients with National Cancer Institute standard- and high-risk B-cell acute lymphoblastic leukemia: A report from the Children’s Oncology GroupJournal of Clinical Oncology.  35:2527-2534. 2017
2017 The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemiaNature Genetics.  49:1211-1218. 2017
2017 Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemiaHaematologica.  102:1391-1400. 2017
2017 Targetable kinase gene fusions in high-risk B-ALL: A study from the Children's Oncology GroupBlood.  129:3352-3361. 2017
2017 Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemiaLeukemia.  31:1278-1285. 2017
2017 No evidence for microsatellite instability in acute myeloid leukemiaLeukemia.  31:1474-1476. 2017
2017 The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemiaLeukemia2017
2017 Clinical relevance of small copy-number variants in chromosomal microarray clinical testingGenetics in Medicine.  19:377-385. 2017
2017 Mutational landscape and gene expression patterns in adult acute myeloid Leukemias with Monosomy 7 as a sole abnormalityCancer Research.  77:207-218. 2017
2016 Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2Leukemia.  30:2254-2258. 2016
2016 MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A Children's Oncology Group StudyLeukemia.  30:1909-1912. 2016
2016 A pilot study of intensified PEG-asparaginase in high-risk acute lymphoblastic leukemia: Children's oncology group study AALL08P1Journal of Pediatric Hematology/Oncology.  38:409-412. 2016
2016 Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: A report from children's oncology group study AALL0232Journal of Clinical Oncology.  34:2380-2388. 2016
2016 Clinical features and gene-and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)Leukemia.  30:1586-1589. 2016
2016 Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia—Comparison among Different Treatment StrategiesMedical and Pediatric Oncology.  63:255-261. 2016
2016 Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnor mal kar yotype at diagnosis: CALGB 8461 (alliance)Haematologica.  101:1516-1523. 2016
2016 Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical featuresCancer Causes and Control.  27:81-91. 2016
2016 Overview of clinical cytogeneticsCurrent protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.].  2016:8.1.1-8.1.13. 2016
2015 Prognostic significance of minimal residual disease in high risk B-ALL: A report from Children's Oncology Group study AALL0232Blood.  126:964-971. 2015
2015 Partial trisomy 21: A fifty-year follow-up visitAmerican Journal of Medical Genetics.  167:1610-1613. 2015
2015 Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemiaLeukemia.  29:567-575. 2015
2015 Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3)Medical and Pediatric Oncology.  62:419-426. 2015
2015 Lymphoid neoplasia: A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adultsBlood.  125:680-686. 2015
2015 Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: A multi-institution, multi-platform microarray studyCancer Genetics.  208:1-18. 2015
2015 Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology group Study AALL0434Medical and Pediatric Oncology.  62:1176-1183. 2015
2015 Variations in dysfunction of sister chromatid cohesion in esco2 mutant zebrafish reflect the phenotypic diversity of Roberts syndromeDisease Models & Mechanisms.  8:941-955. 2015
2014 Expression and prognostic impact of lncRNAs in acute myeloid leukemiaProceedings of the National Academy of Sciences.  111:18679-18684. 2014
2014 Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: Results from children's oncology group study AALL07P4Journal of Clinical Oncology.  32:3874-3882. 2014
2014 Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemiaNew England Journal of Medicine.  371:1005-1015. 2014
2014 SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcomeJournal of Clinical Investigation.  124:1512-1524. 2014
2014 Epigenetics meets genetics in acute myeloid leukemia: Clinical impact of a novel seven-gene scoreJournal of Clinical Oncology.  32:548-556. 2014
2014 Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangementsLeukemia.  28:428-430. 2014
2014 Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: Prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classificationHaematologica.  99:308-313. 2014
2014 An international study of intrachromosomal amplification of chromosome 21 (iAMP21): Cytogenetic characterization and outcomeLeukemia.  28:1015-1021. 2014
2014 Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemiaNature.  508:98-102. 2014
2014 GAS6 expression identifies high-risk adult AML patients: Potential implications for therapyLeukemia.  28:1252-1258. 2014
2014 Identification and use of fluorescent dyes for plant cell wall imaging using high-throughput screeningMethods in Molecular Biology.  1056:103-109. 2014
2014 Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's oncology group study AALL0031Leukemia.  28:1467-1471. 2014
2014 Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: Results from children's oncology group study AALL0031Leukemia.  28:964-967. 2014
2014 Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8Leukemia.  28:1754-1758. 2014
2014 T-DNA-induced chromosomal translocations in feronia and anxur2 mutants reveal implications for the mechanism of collapsed pollen due to chromosomal rearrangementsActa Phytophysiologica Sinica.  7:1591-1594. 2014
2014 The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: A proposed categorization systemGenetics in Medicine.  16:92-100. 2014
2013 A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaLeukemia.  27:2023-2031. 2013
2013 Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: A report from the children's oncology groupJournal of Clinical Oncology.  31:3397-3402. 2013
2013 Lotus Cell Walls and the Genes Involved in its Synthesis and ModificationTropical Plant Biology.  6:152-160. 2013
2013 Reply to K. Orendi et alJournal of Clinical Oncology.  31:2361-2362. 2013
2013 Clinical role of micrornas in cytogenetically normal acute myeloid leukemia: MiR-155 Upregulation independently identifies high-risk patientsJournal of Clinical Oncology.  31:2086-2093. 2013
2013 Genome of the long-living sacred lotus (Nelumbo nucifera Gaertn.)Genome Biology.  14. 2013
2013 New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461Genes, Chromosomes and Cancer.  52:385-401. 2013
2013 The genomic landscape of hypodiploid acute lymphoblastic leukemiaNature Genetics.  45:242-252. 2013
2013 Inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutationsBlood.  121:385-391. 2013
2013 Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemiaBlood.  121:2689-2703. 2013
2012 Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemiaJournal of Clinical Oncology.  30:4515-4523. 2012
2012 Endoscopic ultrasound and endobronchial ultrasound-guided fine-needle aspiration of deep-seated lymphadenopathy: Analysis of 1338 casesCytoJournal.  9. 2012
2012 XAX1 from glycosyltransferase family 61 mediates xylosyltransfer to rice xylanProceedings of the National Academy of Sciences.  109:17117-17122. 2012
2012 Complexes with mixed primary and secondary cellulose synthases are functional in Arabidopsis plantsPlant Physiology.  160:726-737. 2012
2012 Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemiaBlood.  120:2098-2108. 2012
2012 Pediatric acute lymphoblastic leukemia with a t(8;14)(q11.2;q32): B-cell disease with a high proportion of Down syndrome: A Children's Oncology Group studyCancer Genetics.  205:453-458. 2012
2012 RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and microRNA expression signaturesJournal of Clinical Oncology.  30:3109-3118. 2012
2012 The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemiaLeukemia.  26:1713-1717. 2012
2012 Isolation and proteomic characterization of the arabidopsis golgi defines functional and novel components involved in plant cell wall biosynthesisPlant Physiology.  159:12-26. 2012
2012 Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: A Children's Oncology Group StudyBlood.  119:3512-3522. 2012
2012 Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemiaJournal of Clinical Oncology.  30:742-750. 2012
2012 Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: A Children's Oncology Group studyBlood.  119:1872-1881. 2012
2012 Complex analysis of a recurrent pleomorphic hyalinizing angiectatic tumor of soft partsHuman Pathology.  43:121-126. 2012
2011 ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic categoryBlood.  118:6920-6929. 2011
2011 Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemiaBlood.  118:4188-4198. 2011
2011 Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906Medical and Pediatric Oncology.  57:569-577. 2011
2011 Clinical outcome and gene- and microRNA-expression profiling according to the wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B studyHaematologica.  96:1488-1495. 2011
2011 Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disordersAmerican Journal of Medical Genetics.  155:2386-2396. 2011
2011 Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: A susceptibility region for neurological dysfunction including developmental and language delayHuman Genetics.  130:517-528. 2011
2011 Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemiaLeukemia.  25:1365-1368. 2011
2011 Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group Study AALL0232.Journal of Clinical Oncology.  29:3. 2011
2011 Microarray detection of multiple recurring submicroscopic chromosomal aberrations in pediatric T-cell acute lymphoblastic leukemiaLeukemia.  25:1042-1046. 2011
2011 TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: A cancer and leukemia group B studyJournal of Clinical Oncology.  29:1373-1381. 2011
2011 Understanding plant cellulose synthases through a comprehensive investigation of the cellulose synthase family sequencesFrontiers in Plant Science.  2. 2011
2011 Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaNature Genetics.  43:237-241. 2011
2011 Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and mll gene rearrangements: A report from the children's oncology groupJournal of Clinical Oncology.  29:214-222. 2011
2011 Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profilesLeukemia.  25:1555-1563. 2011
2011 Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent mannerNeuro-Oncology.  13:28-41. 2011
2010 Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B studyJournal of Clinical Oncology.  28:5257-5264. 2010
2010 BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B studyBlood.  116:5660-5669. 2010
2010 Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeBlood.  116:4874-4884. 2010
2010 FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B studyBlood.  116:3622-3626. 2010
2010 Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: A report from the Children's Oncology GroupBlood.  116:1045-1050. 2010
2010 Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: A Cancer and leukemia group B studyBlood.  116:788-792. 2010
2010 Identification of a cellulose synthase-associated protein required for cellulose biosynthesisProceedings of the National Academy of Sciences.  107:12866-12871. 2010
2010 Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaBlood.  115:5312-5321. 2010
2010 Raman imaging of cell wall polymers in Arabidopsis thalianaBiochemical and Biophysical Research Communications.  395:521-523. 2010
2010 IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B studyJournal of Clinical Oncology.  28:2348-2355. 2010
2010 Favorable Prognostic Impact of NPM1 Mutations in Older Patients with Cytogenetically Normal de Novo Acute Myeloid Leukemia and Associated Gene- And MicroRNA-Expression Signatures: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology.  28:596-604. 2010
2010 Real-time imaging of cellulose reorientation during cell wall expansion in Arabidopsis rootsPlant Physiology.  152:787-796. 2010
2009 Improved early event-free survival with imatinib in Philadelphia chromosome - Positive acute lymphoblastic leukemia: A Children's Oncology Group StudyJournal of Clinical Oncology.  27:5175-5181. 2009
2009 Rearrangement of CRLF2 in B-progenitor-and Down syndrome-associated acute lymphoblastic leukemiaNature Genetics.  41:1243-1246. 2009
2009 Mutations in UDP-glucose:Sterol glucosyltransferase in Arabidopsis cause transparent testa phenotype and suberization defect in seedsPlant Physiology.  151:78-87. 2009
2009 Label-free in situ imaging of lignification in the cell wall of low lignin transgenic Populus trichocarpaPlanta.  230:589-597. 2009
2009 Molecular cytogenetic characterization of two cases with constitutional distal 11q duplication/triplicationAmerican Journal of Medical Genetics.  149:1516-1522. 2009
2009 Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B studyJournal of Clinical Oncology.  27:3198-3204. 2009
2009 Cellulosic biofuelsAnnual Review of Plant Physiology and Plant Molecular Biology.  60:165-182. 2009
2009 Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemiaBritish Journal of Haematology.  144:930-932. 2009
2008 Distal 22q11.2 microduplication encompassing the BCR geneAmerican Journal of Medical Genetics.  146:3075-3081. 2008
2008 Prognostic significance of, and gene and MicroRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: A cancer and leukemia group B studyJournal of Clinical Oncology.  26:5078-5087. 2008
2008 Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B studyJournal of Clinical Oncology.  26:4595-4602. 2008
2008 Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: The Cancer and Leukemia Group B experienceInternational Journal of Oncology.  33:239-244. 2008
2008 Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group studyBlood.  111:5477-5485. 2008
2008 Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocationBritish Journal of Haematology.  141:827-839. 2008
2008 MicroRNA expression in cytogenetically normal acute myeloid leukemiaNew England Journal of Medicine.  358:1919-1928. 2008
2007 Genetic evidence for three unique components in primary cell-wall cellulose synthase complexes in ArabidopsisProceedings of the National Academy of Sciences.  104:15566-15571. 2007
2007 A previously unrecognized microdeletion syndrome on chromosome 22 Band q11.2 encompassing the BCR GeneAmerican Journal of Medical Genetics.  143:2178-2184. 2007
2007 Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: A report from Children's Oncology Group Study P9201Blood.  110:1105-1111. 2007
2007 High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B studyJournal of Clinical Oncology.  25:3337-3343. 2007
2007 Overlapping phenotype of Wolf-Hirschhorn and Beckwith-Wiedemann syndromes in a girl with der(4)t(4;11)(pter;pter)American Journal of Medical Genetics.  143:1760-1766. 2007
2007 Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemiaGenes, Chromosomes and Cancer.  46:684-693. 2007
2007 Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: A Cancer and Leukemia Group B studyBlood.  109:5164-5167. 2007
2007 Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyCancer Genetics and Cytogenetics.  175:117-124. 2007
2007 Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: A combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Blood.  109:926-935. 2007
2007 Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia [17]Leukemia.  21:1341-1344. 2007
2006 Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A Cancer and Leukemia Group B studyJournal of Clinical Oncology.  24:3904-3911. 2006
2006 Complete trisomy 17p syndrome in a girl with der(14)t(14;17)(p11.2;p11.2)American Journal of Medical Genetics.  140:1647-1654. 2006
2006 Heart disease in pregnancyMedicine.  34:307-311. 2006
2006 Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: Results from Cancer and Leukemia Group B 8461Blood.  108:63-73. 2006
2006 A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies [4]Leukemia.  20:1295-1297. 2006
2006 Studies of a novel sensor for assessing the spatial distribution of cavitation activity within ultrasonic cleaning vesselsUltrasonics.  44:73-82. 2006
2005 Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: A cancer and leukemia group B studyJournal of Clinical Oncology.  23:482-493. 2005
2005 Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: A Cancer and Leukemia Group B studyJournal of Clinical Oncology.  23:9234-9242. 2005
2005 Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A Cancer and Leukemia Group B studyJournal of Clinical Oncology.  23:5705-5717. 2005
2005 High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: A Children's Oncology Group (COG) initiativeLeukemia.  19:734-740. 2005
2005 No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalitiesLeukemia.  19:557-563. 2005
2005 Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): A review of four consecutive childhood AML trials conducted between 1981 and 2000Leukemia.  19:2101-2116. 2005
2004 Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: Results from Cancer and Leukemia Group B study 8461Journal of Clinical Oncology.  22:2410-2418. 2004
2004 Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461Journal of Clinical Oncology.  22:1087-1094. 2004
2004 Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): Results from cancer and leukemia group B study 8461 and review of the literatureCancer.  101:1420-1427. 2004
2004 Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemiaBlood.  103:4036-4042. 2004
2004 Congenital Diaphragmatic Hernia: Is 15q26.1-26.2 a Candidate Locus?American Journal of Medical Genetics.  126 A:183-185. 2004
2004 Congenital diaphragmatic hernia: is 15q26.1-26.2 a candidate locus?American Journal of Medical Genetics.  126A:183-185. 2004
2004 Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: A study of the Cancer and Leukaemia Group BBritish Journal of Haematology.  124:275-288. 2004
2004 Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.Annals of Hematology.  83 Suppl 1. 2004
2004 Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.International Journal of Oncology.  25:143-151. 2004
2004 Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcomeLeukemia.  18:693-702. 2004
2003 BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: A Cancer and Leukemia Group B studyBlood.  102:1613-1618. 2003
2003 Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsLeukemia.  17:700-706. 2003
2003 Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: A case report emphasizing the cytological and cytogenetic findingsHuman Pathology.  34:1354-1357. 2003
2003 Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: Results from CALGB study 9013Leukemia & Lymphoma.  44:39-48. 2003
2002 Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from cancer and leukemia group B (CALGB 8461)Blood.  100:4325-4336. 2002
2002 Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.International Journal of Oncology.  21:1041-1051. 2002
2002 Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshopGenes, Chromosomes and Cancer.  33:401-412. 2002
2001 Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B studyCancer Research.  61:7233-7239. 2001
2001 Transient hyperphosphatasaemia: An important condition to recognizeJournal of Paediatrics and Child Health.  37:359-362. 2001
2001 High frequency of immunophenotype changes in acute myeloid leukemia at relapse: Implications for residual disease detection (Cancer and Leukemia Group B Study 8361)Blood.  97:3574-3580. 2001
2001 Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B studyJournal of Clinical Oncology.  19:2482-2492. 2001
2001 Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 in a boy with a balanced 3;21 translocationAmerican Journal of Medical Genetics.  100:85-86. 2001
2001 T(7;12)(q36;p13) and t(7;12)(q32;p13) - Translocations involving ETV6 in children 18 months of age or younger with myeloid disordersLeukemia.  15:915-920. 2001
2000 New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group report of 343 casesBlood.  96:2543-2549. 2000
2000 Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemiaNew England Journal of Medicine.  342:998-1006. 2000
2000 The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 geneProceedings of the National Academy of Sciences.  97:3497-3502. 2000
2000 Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): A Pediatric Oncology Group studyLeukemia.  14:238-240. 2000
2000 Prognostic factors in children and adolescents with acute myeloid leukemia (exluding children with Down syndrome and acute promyelocytic leukemia): Univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821Leukemia.  14:1201-1207. 2000
2000 Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: A pediatric oncology group studyLeukemia.  14:1570-1576. 2000
1999 Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.Blood.  94:3707-3716. 1999
1999 p27KIP1 Deletions in Childhood Acute Lymphoblastic LeukemiaNeoplasia : An International Journal for Oncology Research.  1:253-261. 1999
1999 Prospective karyotype analysis in adult acute lymphoblastic leukemia: The cancer and leukemia group B experienceBlood.  93:3983-3993. 1999
1999 Detection of mosaicism in amniotic fluid cultures: a CYTO2000 collaborative study.Genetics in Medicine.  1:94-97. 1999
1999 Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: The Pediatric Oncology Group experienceLeukemia.  13:135-141. 1999
1999 Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) TranslocationJournal of Clinical Oncology.  17:191-196. 1999
1999 Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJournal of Clinical Oncology.  17:3767-3775. 1999
1999 Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL, a Pediatric Oncology Group (POG) studyLeukemia.  13:1696-1707. 1999
1998 Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtypeCancer Research.  58:4173-4179. 1998
1998 Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia casesCancer Genetics and Cytogenetics.  105:164-167. 1998
1998 Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A pediatric oncology group pilot studyJournal of Pediatric Hematology/Oncology.  20:229-233. 1998
1998 Chromosome 18q paracentric inversion in a family with mental retardation and hearing lossAmerican Journal of Medical Genetics.  76:372-378. 1998
1998 E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): A pediatric oncology group studyBlood.  91:1021-1028. 1998
1998 Consolidation therapy with antimetabolite-based therapy in standard- risk acute lymphocytic leukemia of childhood: A pediatric oncology group studyJournal of Clinical Oncology.  16:2840-2847. 1998
1998 Myeloperoxidase gene expression in infant leukemia: A pediatric oncology group studyLeukemia & Lymphoma.  29:145-160. 1998
1998 Prevalence of myeloperoxidase gene expression in infant acute lymphocytic leukemiaAmerican Journal of Clinical Pathology.  110:575-581. 1998
1998 Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: A pediatric oncology group studyJournal of Clinical Oncology.  16:2854-2863. 1998
1997 Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B StudyBlood.  90:4532-4538. 1997
1997 Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: Case report and review of the literatureGenes, Chromosomes and Cancer.  20:392-398. 1997
1997 Identification of a recombination event narrowing the Lafora disease gene regionJournal of Medical Genetics.  34:590-591. 1997
1997 Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group studyBlood.  89:3960-3966. 1997
1997 Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from Cancer and Leukemia Group B 8461Journal of Clinical Oncology.  15:466-475. 1997
1997 Secondary cytogenetic changes in acute promyelocytic leukemia - Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: A Cancer and Leukemia Group B studyJournal of Clinical Oncology.  15:1786-1795. 1997
1997 Therapeutic trial for infant acute lymphoblastic leukemia: The pediatric oncology group experience (POG 8493)The American journal of pediatric hematology/oncology.  19:35-42. 1997
1996 Terminal deletion of the long arm of chromosome 4 in a mother and two sonsClinical Genetics.  50:538-540. 1996
1996 Molecular analysis of t(11;19) breakpoints in childhood acute leukemiasBlood.  87:4804-4808. 1996
1996 The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1Oncogene.  12:265-275. 1996
1996 Comparison of Fluorescence in Situ Hybridization, Cytogenetic Analysis, and DNA Index Analysis to Detect Chromosomes 4 and 10 Aneuploidy in Pediatric Acute Lymphoblastic Leukemia: A Pediatric Oncology Group StudyJournal of Pediatric Hematology/Oncology.  18:113-121. 1996
1996 Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group studyJournal of Clinical Oncology.  14:1252-1261. 1996
1996 Molecular analysis of the PML/RARα chimeric gene in pediatric acute promyelocytic leukemiaLeukemia.  10:1296-1302. 1996
1996 Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemiaJournal of Clinical Oncology.  14:18-24. 1996
1995 Paracentric inversions in humans: A review of 446 paracentric inversions with presentation of 120 new casesAmerican Journal of Medical Genetics.  55:171-187. 1995
1995 Chromosome 1p terminal deletion: Report of new findings and confirmation of two characteristic phenotypesJournal of Medical Genetics.  32:619-622. 1995
1995 Heterogeneity in CBFβ/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemiaBlood.  85:3695-3703. 1995
1994 Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: A Pediatric Oncology Group StudyBlood.  84:570-573. 1994
1994 Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhoodCancer Genetics and Cytogenetics.  75:139-144. 1994
1994 Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A pediatric oncology group (POG) study (8600/8493)Cancer Genetics and Cytogenetics.  75:6-10. 1994
1994 The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemiaBlood.  83:330-335. 1994
1994 Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): An update [4]Blood.  83:2384-2385. 1994
1994 Further definition of 20q deletion in myeloid leukemia using fluorescence in situ hybridization [1]Blood.  84:2821-2823. 1994
1994 Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiencyBlood.  84:859-865. 1994
1994 Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosomeLeukemia.  8:1124-1130. 1994
1993 DNA fragments of altered electrophoretic mobility in leukemia samples can arise from double-strand DNA breaks at nuclease hypersensitive sites of active genesCancer Genetics and Cytogenetics.  68:34-41. 1993
1993 Alveolar rhabdomyosarcoma with the t(2;13): Cytogenetic findings and clinicopathologic correlationsMedical and Pediatric Oncology.  21:83-87. 1993
1993 An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocationBlood.  81:2860-2865. 1993
1993 Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: A Pediatric Oncology Group studyBlood.  81:2110-2117. 1993
1993 Erratum: Management of cytogenetic data in multi-center leukemia trials (Computer Methods and Programs in Biomedicine (1993) 40 (269-277))Computer Methods and Programs in Biomedicine.  41:147. 1993
1993 HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalitiesBlood.  81:3197-3203. 1993
1993 Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiencyBlood.  81:3052-3059. 1993
1993 Immunophenotypes and karyotypes of leukemic cells in children with down syndrome and acute lymphoblastic leukemiaJournal of Clinical Oncology.  11:1361-1367. 1993
1993 Management of cytogenetic data in multi-center leukemia trialsComputer Methods and Programs in Biomedicine.  40:269-277. 1993
1993 Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: Implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: A Pediatric Oncology Group studyBlood.  82:1086-1091. 1993
1993 Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: A pediatric oncology group studyLeukemia.  7:2064-2068. 1993
1993 Trisomy 21 in childhood acute lymphoblastic leukemia: A Pediatric Oncology Group Study (8602)Blood.  82:3098-3102. 1993
1993 Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.Recent Results in Cancer Research ==.  131:257-267. 1993
1992 Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B- progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group StudyBlood.  79:3316-3324. 1992
1992 Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemiaBlood.  79:1781-1788. 1992
1992 Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group studyBlood.  80:1316-1323. 1992
1992 Acute megakaryoblastic leukemia in infants with t(1;22)(p13;q13) abnormalityAmerican Journal of Clinical Pathology.  98:214-221. 1992
1992 An Altered 11-Kilobase Transcript in Leukemic Cell Lines with the t(4;11)(q21;q23) chromosome translocationCancer Research.  52:3811-3813. 1992
1992 Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22)Leukemia.  6:535-540. 1992
1992 G19.4(αCD3) x B43(αCD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cellsBlood.  80:2826-2834. 1992
1992 Isochromosomes in childhood acute lymphoblastic leukemia: A collaborative study of 83 casesBlood.  79:2384-2391. 1992
1992 Ploidy of lymphoblasts is the strongest predictor of treatment outcome in b-progenitor cell acute lymphoblastic leukemia of childhood: A pediatric oncology group studyJournal of Clinical Oncology.  10:606-613. 1992
1992 The non-random dic(9;12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosisLeukemia.  6:703-707. 1992
1992 The translocation (1;14)(p34;q11) in human t‐cell leukemia: Chromosome breakage 25 kilobase pairs downstream of the tal1 protooncogeneGenes, Chromosomes and Cancer.  4:211-216. 1992
1992 t(12;17)(p13;q21) in early pre-B acute lymphoid leukemiaLeukemia.  6:251-255. 1992
1992 t(2;14)(p13;q32): A recurring abnormality in lymphocytic leukemia. A pediatric oncology group studyCancer Genetics and Cytogenetics.  58:121-124. 1992
1991 Consistent involvement of the BCR gene by 9;22 breakpoints in pediatric acute leukemiasBlood.  77:324-330. 1991
1991 A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14)Blood.  78:2996-3003. 1991
1991 Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 casesBlood.  77:440-447. 1991
1991 Cytogenetic features of childhood acute lymphoblastic leukemia. A concordance study and a pediatric oncology group studyCancer Genetics and Cytogenetics.  55:249-256. 1991
1991 Heterogeneity of the breakpoint localization in malignant cells with a 9p11 chromosomal abnormalityLeukemia.  5:468-472. 1991
1991 Localization of the expressed human p58 protein kinase chromosomal gene to chromosome 1p36 and a highly related sequence to chromosome 15Genomics.  11:621-629. 1991
1991 Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: A Pediatric Oncology Group studyBlood.  77:1050-1056. 1991
1991 The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemiasBlood.  77:687-693. 1991
1991 The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: A pediatric oncology group studyBlood.  78:748-752. 1991
1990 Coding sequences of the ral-1 gene are disrupted by chromosome translocation in human T cell leukemiaJournal of Experimental Medicine.  172:1403-1408. 1990
1990 The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix - loop - helix proteinEMBO Journal.  9:415-424. 1990
1990 Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid < 45 lineBlood.  75:1170-1177. 1990
1990 Molecular characterization of the t(10;14) translocation breakpoints in T‐cell acute lymphoblastic leukemia: Further evidence for illegitimate physiological recombinationGenes, Chromosomes and Cancer.  2:217-222. 1990
1990 Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhoodBlood.  76:590-596. 1990
1990 Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group studyBlood.  76:489-494. 1990
1990 Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19) (q23;p13): A pediatric oncology group studyBlood.  76:117-122. 1990
1990 Pre-b-cell acute lymphoblastic leukemia in childhoodLeukemia & Lymphoma.  3:1-6. 1990
1990 Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A pediatric oncology group studyJournal of Clinical Oncology.  8:1389-1398. 1990
1990 The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the δ T-cell receptor with TCL3, a conserved and activated locus at 10q24Proceedings of the National Academy of Sciences.  87:3161-3165. 1990
1990 The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group studyBlood.  76:1220-1224. 1990
1989 Light-chain gene expression before heavy-chain gene rearrangement in pre-B cells transformed by Epstein-Barr virusProceedings of the National Academy of Sciences.  86:2356-2360. 1989
1989 Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemiaProceedings of the National Academy of Sciences.  86:4254-4258. 1989
1989 The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemiasScience.  246:379-382. 1989
1988 Aneuploidy and the fragile X syndromeAmerican Journal of Medical Genetics.  30:115-121. 1988
1988 Bone marrow origin of a B-cell lymphomaBlood.  72:94-101. 1988
1988 Interstitial deletion of chromosome 1 [del(1)(q25q32)] in an infant with prune belly sequencePrenatal Diagnosis.  8:169-174. 1988
1988 Regional assignment of six polymorphic DNA sequences on chromosome 21 by in situ hybridization to normal and rearranged chromosomesAmerican Journal of Human Genetics.  42:542-549. 1988
1987 tdic(9;12): A nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: A pediatric oncology group studyBlood.  70:1962-1965. 1987
1987 Preleukemia in Fanconi's anemia: Hematopoietic cell multinuclearity, membrane duplication, and dysgranulogenesisJournal of Submicroscopic Cytology.  19:355-364. 1987
1987 A de novo 3p;8p unbalanced translocation resulting in partial dup(3p) and partial del(8p)Journal of Medical Genetics.  24:174-177. 1987
1987 Lack of association between abnormalities of the chromosome 9 short arm and either 'lymphomatous' features or T cell phenotype in childhood acute lymphocytic leukemiaBlood.  69:735-738. 1987
1987 t(1;19)(q23;p13) in pre-B acute lymphocytic leukemia cell line 697Cancer Genetics and Cytogenetics.  25:379-380. 1987
1986 Localization of the LDHA gene to 11p14→11p15 by in situ hybridization of an LDHA cDNA probe to two translocations with breakpoints in 11p13Human Genetics.  74:331-334. 1986
1986 Establishment of Tac-negative, interleukin-2-dependent cytotoxic cell lines from large granular lymphocytes (LGL) of patients with expanded LGL populationsJournal of Clinical Immunology.  6:457-466. 1986
1986 Granulocytic sarcoma with an indolent course and destructive skeletal disease. Tumor characterization with immunologic markers, electron microscopy, cytochemistry, and cytogenetic studiesCancer.  57:1005-1010. 1986
1986 Lack of association between glutathione content and development of thermal tolerance in human fibroblastsRadiation Research.  106:41-46. 1986
1986 Partial trisomy 6p and partial trisomy 22 resulting from 3:1 meiotic disjunction of maternal (6p;22q) translocationJournal of Medical Genetics.  23:185-187. 1986
1986 Sideroblastic anemia associated with thrombocytosis and a chromosome 3 abnormalityCancer Genetics and Cytogenetics.  22:183-187. 1986
1985 Lymphomatous All with Abnormalities of the Short Arm of Chromosome 9New England Journal of Medicine.  313:1611-1612. 1985
1985 Acute leukemias associated with the 4;11 chromosome translocation have rearranged immunoglobulin heavy chain genesBlood.  66:33-38. 1985
1985 An acute myeloproliferative disorder characterized by myelofibrosis and blast cells that express phenotypic properties associated with multiple hematopoietic lineagesAmerican Journal of Clinical Pathology.  83:114-121. 1985
1985 The clinical utility of cytogenetic analysis in acute leukemia.The Alabama journal of medical sciences.  22:90-93. 1985
1985 Translocation (6;9)(p23;q34) in acute nonlymphocytic leukemia: Three new casesCancer Genetics and Cytogenetics.  18:303-306. 1985
1984 Paternal Robertsonian translocation t(13q;14q) and maternal reciprocal translocation t(7p;13q) in a couple with repeated fetal lossJournal of Medical Genetics.  21:463-464. 1984
1984 Tetraploidy: A report of three live-born infantsAmerican Journal of Medical Genetics.  19:29-37. 1984
1984 Clonal Remission in Acute LeukemiaNew England Journal of Medicine.  311:922-923. 1984
1984 Pre-B cell leukemia associated with chromosome translocation 1;19Blood.  63:721-724. 1984
1984 An unbalanced (6q;13q) translocation in a male with clinical features of Ehlers-Danlos type II syndromeJournal of Medical Genetics.  21:226-228. 1984
1984 Recombination between the fragile X and G6PD.American Journal of Medical Genetics.  17:275-276. 1984
1984 Translocation (9;11)(p21;q23) in a case of acute myeloblastic leukemia (AML-M2)Cancer Genetics and Cytogenetics.  12:329-332. 1984
1983 Unusual translocations t(2;6) and t(?;22) in a child with acute myelocytic leukemiaCancer Genetics and Cytogenetics.  10:205-208. 1983
1982 CYTOGENETICS OF B-CELL LINEAGE ACUTE LYMPHOCYTIC LEUKAEMIAS OF CHILDHOODLancet.  320:1334-1335. 1982
1982 Linkage studies in carriers of Lowe oculo-cerebro-renal syndromeAmerican Journal of Human Genetics.  34:966-971. 1982
1982 Colonic Villous Adenoma: Monoclonal OriginJournal of the American Medical Association.  247:829-830. 1982
1981 Normal activity and electrophoretic mobility of erythrocyte glucose-6-phosphate dehydrogenase in males with X-linked mental retardation and the fragile Xq.American Journal of Human Genetics.  33:826-828. 1981
1980 A new glucose-6-phosphate dehydrogenase deficient variant in a patient with Chediak-Higashi syndromeBlood.  56:476-480. 1980
1980 Wiskott-Aldrich syndrome: Cellular impairments and their implication for carrier detectionBlood.  56:1048-1054. 1980
1980 CELLULAR EXPRESSION OF WISKOTT-ALDRICH ALLELELancet.  315:601-602. 1980
1979 A study of a patient with chronic lymphocytic leukemia (CLL) which demonstrates that proliferation of the lymphocytic clone in CLL does not include T lymphocytesClinical immunology and immunopathology.  13:231-236. 1979
1978 A common progenitor for human myeloid and lymphoid cells [19]Nature.  274:590-591. 1978

Education And Training

  • Doctor of Philosophy in Physiology, University of Alabama at Birmingham 1979
  • Full Name

  • Andrew Carroll